InvestorsHub Logo

rayovacAAA

03/14/20 4:48 PM

#241294 RE: vg_future #241293

AVXL HAS RELEASED TRIAL RESULTS FOR A TOTAL OF 38 PATIENTS WORLD WIDE YET A2-73 AND THE REST OF AVXL'S PIPELINE IS NOT APPROVED!!!!!!


ONLY LOGIC REASON TO EXPLAIN THE ABOVE:



THERE IS A GLOBAL CONSPIRACY BY THE FDA, EMA, TGA, BP AND THE REST OF THE CABAL TO KEEP A2-73 AND THE REST OF AVXL'S PIPELINE FROM THE SICK!!!!!!!!!!


Wrong! There are many biotech companies that jump with results and hold their value and some even get bought pre-revenue. So, market does value pre-revenue companies.

-vg_future




GOOD LUCK AND GOD BLESS!!!!!!!!!!!!

anders2211

03/14/20 6:58 PM

#241303 RE: vg_future #241293

Wrong! There are many biotech companies that jump with results and hold their value and some even get bought pre-revenue. So, market does value pre-revenue companies.



You are right there have been others (thats not what I meant) I meant just so far not Anavex and as it's going now I don't see that change even after wonderful readout this sumer. After readout june-sept Anvavex should, like those other biotechs really start to connect with Wall Street.